Total submissions: 21
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000212352 | SCV000149771 | benign | not specified | 2014-07-17 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV000119120 | SCV000153833 | benign | Hereditary diffuse gastric adenocarcinoma | 2025-02-04 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000115862 | SCV000172889 | benign | Hereditary cancer-predisposing syndrome | 2014-12-03 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV000212352 | SCV000310134 | likely benign | not specified | criteria provided, single submitter | clinical testing | ||
Institute for Biomarker Research, |
RCV000115862 | SCV000576453 | likely benign | Hereditary cancer-predisposing syndrome | 2017-02-14 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000115862 | SCV000684468 | likely benign | Hereditary cancer-predisposing syndrome | 2014-12-09 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000212352 | SCV000860261 | benign | not specified | 2018-04-05 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000679551 | SCV001150947 | likely benign | not provided | 2024-11-01 | criteria provided, single submitter | clinical testing | CDH1: BS2 |
ARUP Laboratories, |
RCV000679551 | SCV001472271 | benign | not provided | 2023-11-03 | criteria provided, single submitter | clinical testing | |
Institute for Clinical Genetics, |
RCV000679551 | SCV002009848 | likely benign | not provided | 2021-11-03 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000115862 | SCV002529191 | benign | Hereditary cancer-predisposing syndrome | 2021-05-02 | criteria provided, single submitter | curation | |
Center for Genomic Medicine, |
RCV000212352 | SCV002551753 | benign | not specified | 2023-08-15 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV003149807 | SCV003837765 | likely benign | Breast and/or ovarian cancer | 2021-08-09 | criteria provided, single submitter | clinical testing | |
European Reference Network on Genetic Tumour Risk Syndromes |
RCV000119120 | SCV003926665 | benign | Hereditary diffuse gastric adenocarcinoma | 2022-08-01 | criteria provided, single submitter | clinical testing | BA1; BS2 (PMID: 30311375) |
Breakthrough Genomics, |
RCV000679551 | SCV005219058 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Myriad Genetics, |
RCV000119120 | SCV005405298 | benign | Hereditary diffuse gastric adenocarcinoma | 2024-09-13 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is intronic and is not expected to impact mRNA splicing. Homozygosity has been confirmed in one or more individuals. As homozygosity for pathogenic variants in this gene is generally assumed to result in embryonic lethality, this variant is unlikely to be pathogenic. |
Mayo Clinic Laboratories, |
RCV000212352 | SCV000691815 | likely benign | not specified | no assertion criteria provided | clinical testing | ||
Diagnostic Laboratory, |
RCV000679551 | SCV001741428 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000212352 | SCV001809005 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000212352 | SCV001921442 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000679551 | SCV001953605 | likely benign | not provided | no assertion criteria provided | clinical testing |